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Introduction
Cellular senescence is an irreversible proliferation arrest that is 
activated in primary human cells by various molecular triggers, 
including shortened telomeres that result from excessive rounds 
of cell proliferation (so-called replicative senescence [RS]; 
Hayflick and Moorhead, 1961; Bodnar et al., 1998); activation 
of oncogenes, such as B-RAF and N-RAS (so-called oncogene-
induced senescence [OIS]; Serrano et al., 1997); and other mo-
lecular stresses (Adams, 2009; Kuilman et al., 2010). Both RS 
and OIS are important tumor suppressor mechanisms in vivo 
(Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; 
Michaloglou et al., 2005; Cosme-Blanco et al., 2007; Feldser 
and Greider, 2007). For example, virtually all benign human 
nevi harbor activating mutations in N-RAS or its downstream 
effector, BRAF (Omholt et al., 2002; Pollock et al., 2003; Gray-
Schopfer et al., 2007). But, typically, benign nevi do not progress 
to melanoma. Melanocytes within human nevi display markers 
of senescence, including cell cycle exit, expression of p16INK4a, 
senescence-associated -galactosidase (SA -gal), and elevated 
DNA damage signaling (Michaloglou et al., 2005; Gray-Schopfer 
et al., 2006; Suram et al., 2012; but see also Tran et al., 2012). 
These data suggest that oncogenic activation of the Ras pathway 
in melanocytes in vivo ultimately triggers senescence to block 
melanoma progression.
Senescence-associated proliferation arrest is driven by 
various interconnected effector pathways, including activation 
of the p16INK4a/pRB and p53/p21CIP1 tumor suppressor path-
ways, elevated DNA damage signaling, and chromatin changes 
(Adams, 2009; Kuilman et al., 2010). In addition, senescence is 
associated with secretion of various growth regulatory factors, 
cytokines and chemokines (the so-called senescence-associated 
secretory phenotype [SASP]; Krtolica et al., 2001). Accumulating 
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ing. Here we show that an autophagy/lysosomal pathway 
processes chromatin in senescent cells. In senescent cells, 
lamin A/C–negative, but strongly -H2AX–positive and 
H3K27me3-positive, cytoplasmic chromatin fragments 
(CCFs) budded off nuclei, and this was associated with 
lamin B1 down-regulation and the loss of nuclear envelope 
integrity. In the cytoplasm, CCFs were targeted by the 
autophagy machinery. Senescent cells exhibited markers 
of lysosomal-mediated proteolytic processing of histones 
and were progressively depleted of total histone content in 
a lysosome-dependent manner. In vivo, depletion of his-
tones correlated with nevus maturation, an established 
histopathologic parameter associated with proliferation 
arrest and clinical benignancy. We conclude that senes-
cent cells process their chromatin via an autophagy/ 
lysosomal pathway and that this might contribute to sta-
bility of senescence and tumor suppression.
Lysosome-mediated processing of chromatin  
in senescence
Andre Ivanov,1 Jeff Pawlikowski,1 Indrani Manoharan,1 John van Tuyn,1 David M. Nelson,1 Taranjit Singh Rai,1 
Parisha P. Shah,3 Graeme Hewitt,4 Viktor I. Korolchuk,4 Joao F. Passos,4 Hong Wu,2 Shelley L. Berger,3  
and Peter D. Adams1
1Institute of Cancer Sciences, CR-UK Beatson Laboratories, University of Glasgow, Glasgow G61 1BD, Scotland, UK
2Fox Chase Cancer Center, Philadelphia, PA 19111
3University of Pennsylvania, Philadelphia, PA 19104
4Institute for Ageing and Health, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne NE1 7RU, England, UK
© 2013 Ivanov et al. This article is distributed under the terms of an Attribution–Noncommercial– 
Share Alike–No Mirror Sites license for the first six months after the publication date (see 
http://www.rupress.org/terms). After six months it is available under a Creative Commons 
























JCB • VOLUME 202 • NUMBER 1 • 2013 130
containing CCFs, the mean number of CCFs per cell was 1.65 ± 
0.7. Thus, under steady-state conditions, a sizable minority of 
cells contain 1–3 CCFs.
Cytoplasmic chromatin fragments generated in senescent 
cells lacked nuclear lamin A/C (Fig. 1, C and D), in contrast 
to micronuclei generated by mitotic poisons such as Eg5 
inhibitor III, of which 90% were lamin A/C positive (Fig. S1 B 
and unpublished data); hence designation of the former as CCFs 
rather than micronuclei. Pointing to a selective mode of forma-
tion of these CCFs, they stained positive for heterochromatic 
histone mark (H3K27me3), negative for euchromatic histone 
mark (H3K9ac; Fig. 1, E and F), and more intensely for H3 than 
the main cell nucleus (Fig. 1 A and Fig. S1 C). Indicating the 
specificity of the immunofluorescence staining, in proliferating 
cells, H3K27me3 was enriched in the presumptive inactive 
X-chromosome of these female IMR90 cells, whereas H3K9ac 
was excluded (Fig. S1 B).
Surprisingly, and again in contrast to micronuclei generated 
by Eg5 inhibitor III (Fig. S1 B), the vast majority of CCFs stained 
strongly for -H2AX (Fig. 1 G and Fig. S1 E), but not for other 
DNA damage markers, such as 53BP1 (Fig. 1 G). As expected, 
nuclear -H2AX foci colocalized with 53BP1 (Fig. 1 G). How-
ever, we observed that CCF-positive cells contain fewer intranu-
clear -H2AX/53BP1 foci than CCF-negative cells (Fig. 1 H). 
-H2AX–positive CCFs were also detected in RS human melano-
cytes and RS human mesenchymal progenitor cells (hMPCs), as 
well as in mouse hepatocytes in vivo (Fig. S1 F). Specifically, in 
16-mo-old C57BL/6 mice (n = 3), 2.48 ± 0.32% hepatocytes con-
tained CCFs. In sum, a proportion of senescent cells contain 
-H2AX–positive and H3K27me3-positive CCFs.
Formation of CCF is associated with 
nuclear-to-cytoplasmic chromatin blebbing
To investigate formation of CCFs in senescence, we transfected 
near-senescent cells with histone H2B fused at its N terminus to 
GFP (GFP-H2B) and performed time-lapse fluorescence imaging 
of live cells. Remarkably, we observed fragments of GFP-H2B 
“blebbing” off the main cell nucleus of nonmitotic senescent cells 
(Fig. 2 A; Fig. S2 A; and Video 1). Similarly, we observed appar-
ent nuclear blebbing by staining fixed senescent cells with anti-
bodies to histone H3 (Fig. S2 B) and -H2AX (Fig. 2 B). Although 
nuclear-to-cytoplasmic chromatin blebbing has been reported re-
cently in cancer cell lines (Vargas et al., 2012), the accumulation 
of cells containing CCFs is consistent with an increase in the 
frequency of this process in senescent human cells. We con-
clude that senescent cells lose histone-enriched H3K27me3- 
and -H2AX–positive chromatin to the cytoplasm by extrusion 
of chromatin through the nuclear envelope.
The observation that chromatin escapes the nucleus of senes-
cent cells suggested that the nuclear envelope might suffer a loss of 
integrity. To investigate this, we compared expression and localiza-
tion of the nuclear lamins that underlie the nuclear membrane 
in proliferating and senescent cells. As recently reported (Shimi 
et al., 2011; Freund et al., 2012), abundance of lamin B1 was 
markedly down-regulated in RS and OIS fibroblasts in vitro 
(Fig. 2, C and D). In particular, lamin B1 was depleted from the 
perinuclear region, presumably underlying the nuclear envelope 
evidence indicates that the SASP facilitates control of neo-
plastic, potentially transformed cells, by the immune system 
(Xue et al., 2007; Krizhanovsky et al., 2008; Kang et al., 2011; 
Sagiv et al., 2012).
Evidence also suggests that the lysosomal compartment, 
being up-regulated in senescence (Lee et al., 2006), plays an im-
portant role in senescence-associated cell cycle arrest and genera-
tion of the SASP (Young et al., 2009), at least in the context of 
OIS. Expression of the SASP is dependent on a specific cellular 
compartment, dubbed the TOR-autophagy spatial coupling com-
partment (TASCC), where the autophagic catabolic pathway is 
spatially and temporally linked to the mTOR-associated anabolic 
pathway, allowing protein degradation to feed raw materials 
directly into protein synthesis for the SASP (Narita et al., 2011). 
Flux through linked autophagic (inhibited by mTOR) and protein 
synthetic (activated by mTOR) pathways is consistent with the 
ability of rapamycin, an inhibitor of mTOR and activator of au-
tophagy, to both activate and inhibit features of senescence 
(Demidenko et al., 2009; Cao et al., 2011; Kennedy et al., 2011; 
Iglesias-Bartolome et al., 2012).
Altered chromatin structure also controls senescence. 
Many senescent cells accumulate specific subnuclear heterochro-
matic compartments, called senescence-associated heterochro-
matin foci (SAHF; Narita et al., 2003). These chromatin-dense 
domains are believed to embed and silence genes responsible for 
cell cycle progression (Narita et al., 2003; Zhang et al., 2005, 
2007), thus facilitating senescence-associated terminal prolifera-
tion arrest. Also, it has been shown that the formation of SAHF 
protects against excessive DNA damage signaling during onco-
genic stress (Di Micco et al., 2011). However, the nature of the 
link, if any, between autophagy and chromatin in senescent cells 
is unknown.
Here we show that senescent cells extrude fragments of 
chromatin from the nucleus into the cytoplasm. These cytoplas-
mic chromatin fragments (CCFs) lack a nuclear envelope and 
are -H2AX–positive and H3K27me3-positive, but 53BP1- and 
H3K9ac-negative. CCFs are processed in the cytoplasm by an 
autophagic/lysosomal pathway. Processing of CCFs is associ-
ated with reduced histone content in senescent cells and this is 
prevented by lysosomal inhibitors. Together, these findings re-
veal a dynamic process of ongoing chromatin metabolism in 
senescent cells.
Results
Cytoplasmic chromatin fragments in 
senescent cells
While comparing chromatin of proliferating and senescent cells, 
we noted chromatin changes in senescent cells in addition to 
SAHF (Narita et al., 2003), a well-documented feature of senes-
cence. Specifically, in both RS and OIS, we noted an increase in 
the proportion of cells harboring DAPI- and strongly histone 
H3-stained CCFs, outside of the main cell nucleus (Fig. 1, A 
and B). In populations of senescent cells (both RS and OIS), 
where the majority of the cells were senescent as judged by SA 
-gal and cell cycle exit, the proportion of cells containing CCFs 
typically did not exceed 20% (Fig. S1 A). Among those cells 
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Figure 1. Cytoplasmic chromatin fragments in senescent cells. (A) Cytoplasmic chromatin fragments (CCFs) in senescent cells are strongly positive for his-
tone H3. Yellow arrow marks CCF. (B) Increased proportion of cells with CCFs in RS or OIS. Mean ± SEM, n = 3; P < 0.01 (OIS), P < 0.002 (RS). Assays 
were performed 10 d after induction with tamoxifen (OIS) or 4 wk after the last passage and >90% SA -gal+ (RS). (C) CCFs in OIS cells are lamin A/C 
negative. (D) Cells from C were scored for lamin A/C+ and lamin A/C CCFs. Note that the majority of micronuclei in control cells are lamin A/C positive. 
Mean ± SEM, n = 3; P < 0.0006 for lamin A/C negative CCF con vs. OIS; P < 0.6 for lamin A/C positive CCF con vs. OIS. (E) CCFs in OIS are strongly 
positive for heterochromatic histone mark H3K27me3 but not for euchromatic mark H3K9ac. (F) Cells from E were scored for indicated histone modifica-
tions in CCFs. A single representative experiment is shown and at least 100 cells were scored per slide. Note the majority of micronuclei in control cells 
are positive for both marks. (G) CCFs in RS contain -H2AX but not 53BP1 (top). Intranuclear -H2AX foci colocalize with 53BP1 (bottom). (H) CCF+ and 
CCF cells from G were scored for colocalizing intranuclear -H2AX and 53BP1 foci. Mean ± SEM, n = 3; P < 0.019. Bars (in IF panels), 10 µm.
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Figure 2. Nuclear-to-cytoplasm chromatin blebbing in senescent cells associated with depletion of lamin B1. (A) Extrusion of GFP-H2B–positive chromatin 
fragment from nonmitotic RS nucleus. Confocal time-lapse microscopy of transiently transfected GFP-H2B–expressing cell, 60× original magnification, 150 nm 
optical section, time in mins. Bars: 10 µm; (insert) 2 µm. (B) Chromatin fragments blebbing out of nucleus are -H2AX positive. Bars: (top) 10 µm; (bottom) 
5 µm. (C) Down-regulation of lamin B1 and lamin B receptor (LBR) in RS cells, assayed by Western blot. See Materials and methods for time-course details. 
(D) Depletion of lamin B1 from OIS cells, assayed by immunofluorescence. (E) A line-scan of lamin B1 fluorescence intensity along the arrows in D. Data 
shown are from a single representative experiment out of three repeats. (F) Depletion of lamin B1 in BRAFV600E-induced OIS melanocytes in vitro. Bars, 
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Strikingly, we invariably observed that CCFs in senescent cells 
were closely juxtaposed to a p62 body (Fig. 4, A and B; and 
Fig. S3 C). Indeed, frequently the p62 body appeared to nestle 
within an inclusion in the chromatin fragment (Fig. S3 C). Impor-
tantly, sites of CCFs and p62 juxtaposition are distinct from 
the TASCC previously described in senescent cells (Narita 
et al., 2011), as less than 0.5% of CCFs overlapped with TASCC 
(Fig. S3 D). In the autophagy pathway, p62 serves as an adap-
tor between LC3-II in the autophagosome and ubiquitinated 
target proteins or aggregates (Pankiv et al., 2007). Therefore, 
we asked whether CCFs in senescent cells are ubiquitinated. 
Indeed, p62 and conjugated ubiquitin (detected by FK2 anti-
body) often partially colocalized in CCFs (Fig. 4 C; and Fig. S3, 
E and F). Moreover, consistent with ubiquitin being an adaptor 
between the chromatin and p62, ubiquitinated proteins were 
seemingly most enriched at the chromatin surface (Fig. 4 D). 
The p62–ubiquitin interaction directs substrates to the autopha-
gic/lysosomal proteolysis pathway and, concordant with this, in 
senescent cells we observed increased expression of the proteo-
lytically cleaved, activated form of cathepsin L, a lysosomal 
protease (Fig. 4 E and Fig. S3 G; Ishidoh et al., 1998). This was 
accompanied by accumulation of histone H3cs1, a modified 
form of H3 that results from N-terminal proteolysis of H3 by 
cathepsin L (Fig. 4, F and G; Duncan et al., 2008). As expected 
from lysosomal degradation of CCFs, H3cs1 was present pre-
dominantly in the cytoplasm (Fig. 4 H).
Consistent with histone proteolysis in senescent cells, we 
observed that senescent cells were depleted of total histone con-
tent, based on immunofluorescence assays (Fig. 5, A and B; and 
Fig. S4 A). Moreover, we observed by Western blot that senes-
cent fibroblasts generated either through RS or OIS showed a 
progressive decline in histone content over a period of weeks 
(Fig. 5 C and Fig. S4 B) after they were judged senescent by 
expression of SA -gal, p16INK4a, and repression of cyclin A 
(Fig. 5 C; and Fig. S4, B and C). Underscoring the reduced histone 
content of senescent cells, cells exhibiting SAHF stained less in-
tensely for histone H3 than did cells without SAHF (Fig. 5 A), 
even though SAHF are, in part, defined by their intense staining 
for heterochromatic histone marks (Narita et al., 2003; Zhang 
et al., 2005).
To confirm that senescent cells become depleted of histone 
content, we established conditions to measure DNA in whole-cell 
lysates prepared in buffer containing 2% SDS. Using fluoromet-
ric DNA quantitation assay we found that measurements of DNA 
concentration were linear with respect to input-purified human 
genomic DNA or dilution of cell crude lysate over the relevant 
concentration range (Fig. S4, D and E). This assay was used to 
Western blot whole-cell lysates from proliferating and senescent 
cells, normalized for equal DNA content. This confirmed that 
(Fig. 2, D and E). Those cells with reduced lamin B1 also exhib-
ited marked SAHF (Fig. S2, C and D). In addition, expression of 
lamin B receptor (LBR) was also repressed in senescent cells 
(Fig. 2 C). Similar results were obtained with BRAFV600E- 
induced senescent melanocytes (Fig. 2, F and G), as well as in 
melanocytes undergoing RS (Fig. S2 E). Senescent nevus melano-
cytes in vivo were also deficient in lamin B1, compared with non-
senescent epidermal keratinocytes (Fig. S2 F) and melanocytes 
(presumably nonsenescent) positioned along the neighboring base-
ment membrane (Fig. 2, H and I). Campisi and coworkers also 
reported that lamin B1 is down-regulated in senescent cells in vivo, 
specifically in liver of irradiated mice (Freund et al., 2012). 
Although expression of lamin A/C was largely unchanged in senes-
cence, we did observe relocalization of lamin A/C in senescent 
cells, away from the perinuclear region (Fig. S2 G). Together, these 
results suggest the nuclear envelope is structurally compromised in 
senescent cells, perhaps facilitating nuclear blebbing.
In fact, in some senescent cells, we observed herniation 
of chromatin through the perinuclear lamin B1 network (Fig. 3, 
A and B), consistent with the idea that the barrier function of the 
nuclear membrane of senescent cells is compromised. To directly 
test this, we harvested nuclei from proliferating and senescent 
cells, incubated them with fluorescent high molecular weight 
dextrans, either 70- or 500-kD, and scored uptake by fluores-
cence microscopy. The nuclei of senescent cells were more per-
meable to both dextrans (Fig. 3, C and D). Underscoring the link 
between senescence and envelope permeability, nuclei exhibiting 
SAHF were invariably permeable to dextrans (Fig. 3, E and F). 
Significantly, in individual nuclei, we also observed that chro-
matin extrusion and dextran intrusion occurred in close physi-
cal proximity (Fig. 3 G). These results show that down-regulation 
of lamin B1 in senescent cells is linked to unselective permea-
bility of the nuclear envelope and loss of nuclear chromatin to 
the cytoplasm.
Lysosomal/autophagic processing of 
histones in senescence
Next, we considered the fate of the CCFs in senescent cells. 
Senescent cells up-regulate autophagy, and this recycling pro-
cess is required for secretion of inflammatory cytokines by se-
nescent cells (Young et al., 2009). Hence, we hypothesized that 
CCFs might be substrates for the autophagy/lysosomal processing 
pathway. To test this, we compared the localization of the CCFs 
to p62SQSTM (p62), an adaptor protein that directs protein 
aggregates into the autophagy pathway (Pankiv et al., 2007). 
Consistent with an increase in autophagy, in senescent cells we 
observed increased staining of both presumptive lysosomes 
(with Lysotracker red) and p62, the latter in the form of charac-
teristic focal “p62 bodies” (Lamark et al., 2003; Fig. S3, A and B). 
10 µm. (G) Quantitative immunofluorescence of lamin B1 in melanocytes from F. A representative experiment out of two repeats is shown. At least 150 
randomly selected cells were assessed. (H) Senescent nevus melanocytes (n) stain less intensely for lamin B1 as compared with nonsenescent melanocytes 
in epidermis (e). White dotted line shows the basement membrane between the dermis and epidermis. Bottom panels (Epi and Nevus) are expanded from 
white boxed areas on top. Confocal microscopy for DAPI (blue), MelanA (red), and lamin B1 (green) stained tissue. Bars, 20 µm. (I) Quantitation of results 
from H for three different nevi. Epifluorescence images of lamin B1– and MelanA-stained nevi were obtained and epidermal or nevus MelanA–positive cells 
were scored for the presence (positive) of a characteristic lamin B1 “ring.” At least 50 MelanA-expressing epidermal melanocytes and at least 100 nevus 
melanocytes were scored. Average of three different nevi ± SEM; P < 0.0005.
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Figure 3. Blebbing of chromatin from nucleus to cytoplasm in senescent cells is associated with loss of nuclear envelope integrity. (A) Herniation of H3K27me3-
positive chromatin into the cytoplasm of OIS cells. Yellow boxed area is magnified in bottom panels. Bars: (top panels) 10 µm; (bottom panels) 5 µm. 
(B) Quantitation of lamin B1 gaps or herniations in OIS. Mean ± SEM, n = 2; P < 0.01. (C) Isolated nuclei of senescent cells are permeable to both 70- and 
500-kD dextrans, indicating impairment of the barrier function of nuclear envelope. Dark nuclei exclude fluorescent dextran. Bars, 10 µm. (D) Quantitation 
of results from C. Mean ± SD, n = 4; P < 0.000001 for both 70- and 500-kD dextrans. (E) Representative OIS SAHF+ nucleus showing dextran permeability. 
Bars, 10 µm. (F) Quantitation of dextran 70 uptake in SAHF+ and SAHF OIS cells. P < 1.9 × 105. (G) In individual nuclei, chromatin extrusion and dextran 
intrusion occurred in close physical proximity. Right-hand panels are expanded from yellow boxed areas on the left. Bars: (left) 10 µm; (right) 2 µm.
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Figure 4. Cytoplasmic histone is processed by a lysosomal/autophagy pathway. (A) Close juxtaposition of senescence-associated CCF (RS) with p62 
nuclear bodies. Bars: 10 µm; (inset) 1 µm. (B) Quantitation of control and OIS cells with CCF overlapping p62 (p62+) or not (p62). Mean ± SEM, n = 3. 
(C) Quantitation of proliferating and RS cells with CCF overlapping p62 (p62+) or not (p62) and protein ubiquitination (FK2+) or not (FK2). Mean ± 
SEM, n = 3; P < 0.0008 for FK2+/p62+ CCF, comparing proliferating and RS cells. (D) Ubiquitinated proteins appear to line chromatin surface in CCF. 
Yellow boxed areas are magnified in right-hand panels. Bars: (left panels) 10 µm; (right panels) 1 µm. (E) Apparent activation of cathepsin L in RS IMR90 
cells. In contrast to RS cells, the majority of cathepsin L in proliferating control cells exists in its inactive pro-cathepsin L form. Loading was normalized by 
cell number and lamin A/C was used as a loading control. See Materials and methods for details of time course. (F) Accumulation of H3cs.1, a specific 
N-terminal cleavage product of H3, in OIS cells. See Materials and methods for details of time course. Western blotting was performed using the same 
cellular lysates as in Fig. S4 B, and the same lamin A/C panel is shown in both figures. (G) Accumulation of H3cs.1 and corresponding high mobility H3 
in OIS. (H) Predominant cytoplasmic localization of H3cs.1 in senescent cells. -Tubulin and lamin A/C were used as fractionation controls for cytoplasmic 
and nuclear fractions, respectively.
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Figure 5. Senescent cells in vitro and in vivo contain reduced histone content. (A) Immunofluorescent confocal images of histone H3 in control or OIS 
cells (11 d after activation of ER-RASG12V). Yellow arrows indicate cells with most pronounced SAHF. (B) Quantitative immunofluorescence analysis of 
histone H3 in RS and OIS cells. Representative of two independent experiments. (C) Progressive loss of core histones in senescent IMR90 cells in replicative 
senescence (RS). Lysates were normalized by cell number and an equal number of cells was loaded per each lane. Lamin A/C was used as a confirmatory 
loading control. See Materials and methods for details of time course. (D) Immunohistochemistry for histone H3 in human dermal nevus (n) and adjacent 
epidermis (e). Right-hand panels are expanded from boxed areas on the left. Note decreased nevus staining for H3 (right bottom) as compared with epidermis 
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be linked to enhanced tumor suppression in melanocytic neopla-
sia. The lysosomal compartment plays a role in this senescence-
associated degradation of histones.
Lamin B1 has been previously shown to be down-regulated 
in senescent cells (Shimi et al., 2011; Freund et al., 2012). Here 
we extend these observations to show that lamin B1 is dramati-
cally down-regulated in vivo in senescent melanocytes of benign 
human nevi. We also show in vitro that this down-regulation is 
linked to permeabilization of the nuclear envelope and loss of 
chromatin from the nucleus to the cytoplasm. Significantly, Yang 
et al. (2011) previously reported an increased frequency of nu-
clear blebbing in in vitro cultured lamin B1/B2-null keratino-
cytes. On the other hand, lamin B1 and lamin B2 knockout mice 
die shortly after birth (Vergnes et al., 2004; Coffinier et al., 2010). 
Clearly, B-type lamins do have essential functions, but this is 
context dependent. We also note that senescent cells retain ex-
pression of lamin B2 (Shimi et al., 2011; Freund et al., 2012).
Interestingly, defects in nuclear envelope morphology and 
integrity, including herniations of the nuclear envelope (Bridger 
and Kill, 2004; Goldman et al., 2004; Scaffidi and Misteli, 2005), 
are also a feature of the progeroid aging syndrome Hutchinson-
Gilford progeria syndrome (HGPS), frequently caused by a 
splicing mutation in the lamin A gene. This mutation generates a 
cryptic splice site in exon 11, thereby deleting a proteolytic 
cleavage site in the variant lamin A protein (progerin). This, in 
turn, leads to incomplete protein processing and accumulation of 
mislocalized progerin in the nuclear envelope (Butin-Israeli 
et al., 2012). Other mutations in the lamin A gene have also been 
linked to the aberrant nucleocytoplasmic compartmentalization, 
apparently due to ruptures in the nuclear envelope (De Vos et al., 
2011; Houben et al., 2013). Together, this suggests that defects 
in the nuclear lamina are linked to impaired containment of chro-
matin in cell senescence, premature aging, and other laminopa-
thies. The A- and B-type lamins are thought to form separate, but 
interacting, fibrillar networks (Shimi et al., 2008) underlying the 
nuclear envelope, and their functions and regulation have been 
suggested to be relatively nonredundant (Butin-Israeli et al., 
2012). Hence, it is conceivable that impairment of either the 
A- or B-type lamin network can lead to a loss of the nuclear 
envelope integrity.
We found that lamin A/C–negative CCFs are strongly posi-
tive for both heterochromatic histone mark H3K27me3 and 
-H2AX. Conceivably, enrichment of -H2AX in CCFs may 
reflect a role in routing of damaged genome fragments out of 
the nucleus and targeting them to the autophagy machinery, as 
reflected by a close association of -H2AX–positive ubiqui-
tinated CCFs with p62 bodies. Indeed, the fact that CCF-positive 
cells have a tendency to contain less intranuclear DDR foci 
indirectly supports this hypothesis. Alternatively, the fact that 
CCFs are negative for 53BP1 might also suggest a non-DDR 
total histone content is reduced in senescent cells (Fig. S4 F). Our 
ability to detect depletion of histones using multiple antibodies 
(including two different antibodies to histone H4; Fig. 5 C) re-
duces the likelihood that the observation depends on altered epit-
ope exposure (antigenicity) between proliferating and senescent 
cells. Previous studies showed that senescent yeast and fibroblasts 
in vitro contain reduced amounts of histone and/or harbor his-
tone-depleted regions of the genome (Dang et al., 2009; Feser 
et al., 2010; O’Sullivan et al., 2010). Here we conclude that senes-
cent human cells are progressively depleted of histones, and, im-
portantly, this phenomenon occurs, at least partly, after onset of 
senescence judged by cell cycle exit and expression of SA -gal.
To test whether senescent cells are depleted of histones in 
vivo, we stained nevi for histones. On average, nevus melanocytes 
stained less intensely for histone H3, compared with nonsenescent 
epidermal keratinocytes and melanocytes (Fig. 5, D–G). Impor-
tantly, in nevi, we observed that the proportion of nuclei with low 
histone content increased in the deeper portion of the neoplasm, 
away from the skin surface (Fig. 5 D and Fig. S5, A–C). In contrast, 
expression of p16INK4a, a commonly applied marker of senes-
cence, stained heterogeneously through the nevus as reported 
previously (Michaloglou et al., 2005), in no obvious pattern 
(Fig. S5 D). The deeper portion of a nevus is considered more 
“mature,” a phenomenon that is poorly defined at the molecular 
level but is associated with a lower proliferative index and, impor-
tantly, is inversely linked to malignancy (Smolle et al., 1989a,b; 
Barnhill et al., 2004; Glatz et al., 2010; Ruhoy et al., 2011).
To test whether lysosomes are involved in processing of 
histones in senescent cells, we treated the cells with bafilomycin 
A or concanamycin A, inhibitors of lysosome acidification 
(Klionsky et al., 2008). This treatment antagonized the decrease 
in histone content (Fig. 6, A–C) and production of H3cs1 (Fig. 6, 
D and E). Importantly, bafilomycin A inhibited the autophagic/
lysosomal machinery as indicated by accumulation of cleaved/
lipidated LC3-II (Fig. 6, C–E; Klionsky et al., 2008), but did not 
affect the wider senescence program, as reflected in expression of 
p16INK4a and repression of cyclin A (Fig. 6 D; Kuilman et al., 
2010). This suggests that the effect of bafilomycin A reflects a 
direct effect of autophagy/lysosomes on histone dynamics. Taken 
together, these results indicate that autophagy and lysosomes 
contribute to proteolytic processing of histones in senescence.
Discussion
In this study we show that down-regulation of lamin B1 in se-
nescent cells is linked to permeability of the nuclear envelope 
and dispersal of chromatin fragments (CCFs) from the nucleus 
to the cytoplasm, where they are targeted by the lysosomal/ 
autophagy machinery. Total histone content is progressively 
decreased in senescent cells in vitro, and in vivo this appears to 
(right top). Bars: (left) 100 µm; (right) 50 µm. (E) Immunofluorescence of histone H3 (red) and S100 (melanocytes [green]) in human benign nevus and 
adjacent epidermis. Bars, 20 µm. (F) Higher magnification of boxed regions in E shows reduced staining for H3 in nevus (bottom panels), compared with 
epidermal melanocytes (top panels). Bars, 20 µm. (G) Quantitative immunofluorescence of H3 in epidermal and nevus melanocytes. Images were obtained 
in blue (DAPI), green (S100), and red (H3) channels and then H3 intensity was measured in either S100+ epidermal cells, strictly adjacent to the basal 
membrane, or in S100+ nevus melanocytes. H3 intensity histograms represent fluorescence intensity distribution, combined from three individual nevi. 
At least 150 epidermal (50 per nevus) and 300 nevus (100 per nevus) melanocytes were assessed.
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McManus and Hendzel, 2005) and heat shock–treated cells 
(Hunt et al., 2007; Laszlo and Fleischer, 2009). Taken together, 
these reports suggest that DNA damage–independent formation 
of -H2AX is quite common, although the mechanism and 
function of this phenomenon is yet to be defined.
We observed that core histones are progressively de-
creased during senescence. Genome site-specific and/or overall 
loss of core histones in senescence has been previously reported 
for yeast (Dang et al., 2009; Feser et al., 2010) and fibroblasts 
role for at least a proportion of -H2AX in senescent cells. In-
terestingly, formation of -H2AX foci unlinked to downstream 
DDR signaling has been reported previously in cellular senes-
cence induced by some non-DNA damaging agents (Pospelova 
et al., 2009). Other studies have also shown that phosphory-
lation of H2AX can occur in the absence of DNA damage 
(Soutoglou and Misteli, 2008; Ziegler-Birling et al., 2009). 
Dissociation of H2AX phosphorylation from DNA damage 
has also been reported for normal mitotic (Ichijima et al., 2005; 
Figure 6. Senescence-associated loss of histones is V-ATPase dependent. (A) Bafilomycin A1 (BafA1) blocks the loss of nuclear histone H3 content in cells 
undergoing OIS. BafA1 was added to cells at 50 nM on day 5 after RASG12V induction. Cells were harvested 24 h later, and stained for histone H3. 
Bars, 10 µm. (B) Quantitative histone H3 immunofluorescence in cells from A. Single representative experiment out of three repeats. (C) RASG12V-induced 
OIS cells were treated with BafA1 as described in A and then assessed for histones by Western blot. LC3 I/II has been used as a control for BafA1 activity. 
Lysates from 10,000 cells were loaded per well. (D) BafA1 blocks the accumulation of H3cs.1 in cells undergoing OIS. (E) BafA1 and concanamycin A 
(Con A) block the accumulation of H3cs.1 in RS cells.
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(Fraga et al., 2005; Michishita et al., 2008; Dang et al., 2009; 
Feser et al., 2010; Greer et al., 2010; Peleg et al., 2010; Siebold 
et al., 2010; Wood et al., 2010; Kreiling et al., 2011; Maures 
et al., 2011; Kanfi et al., 2012).
Histone loss was also observed in nevus melanocytes in vivo. 
Interestingly, in contrast to lamin B1 that was largely decreased in 
both the less (superficial) and more mature (deep) regions of the 
nevus, depletion of histones was most marked in the more mature 
component. Thus, both in vitro and in vivo, down-regulation of 
lamin B1 is associated with senescence-associated proliferation 
arrest, whereas progressive depletion of histones in part reflects a 
more advanced stage of senescence, perhaps reflecting senescence 
“maturation” or “deep senescence.” Accordingly, the more mature 
region of a nevus might be considered to be in a state of deep se-
nescence. Consistent with this idea, the rare mitotic cells observed 
within nevi are found at lower frequency in the more mature lower 
portion of the nevus (Ruhoy et al., 2011). Importantly, nevus matu-
ration is inversely linked to malignancy (Smolle et al., 1989a,b; 
Barnhill et al., 2004; Glatz et al., 2010; Ruhoy et al., 2011). Hence, 
deep senescence might equate to enhanced senescence-associated 
proliferation arrest and tumor suppression.
Materials and methods
Cell lines and tissue culture
Human fetal lung IMR90 diploid fibroblasts were purchased from the Amer-
ican Type Culture Collection and cultured at 2–4% oxygen in DMEM (phe-
nol red free) supplemented with 20% FBS, l-glutamine, and antibiotics. For 
ER-RAS induction, ER-RAS–IMR90 cells were supplemented with 100 nM of 
4-hydroxytamoxifen (4-OHT) and maintained in 4-OHT–containing me-
dium until harvesting.
Lightly pigmented neonatal human epidermal melanocytes (Invitro-
gen) were cultured in medium 254 with human melanocyte growth sup-
plement (HMGS), 100 U/ml penicillin, and 100 µg/ml streptomycin (all 
from Invitrogen).
In experiments where proliferating and RS cells or control and OIS 
cells were directly compared at single time points, the assays were per-
formed between days 10 and 15 after ER-RASG12V induction for OIS and 
between weeks 4 and 5 after last split for RS (and at least 90% SA -gal+ and 
absence of observable proliferation). In time-course experiments (Figs. 2 C, 
4 E, and 5 C), cells harvested 3 weeks after the last split (and at least 90% 
SA -gal+ and absence of observable proliferation) were considered week 1. 
In OIS time-course experiments using ER-RASG12V (Fig. 4 F and Fig. S4 B), 
week 1 was harvested 1 week after the addition of tamoxifen. For both RS 
and OIS, subsequent time points were collected at weekly intervals.
Vectors, transfections, and viral infections
The following vectors were used in this study: pLNC-ER-H-RASG12V, encod-
ing a fusion protein of the estrogen receptor (ER) ligand-binding domain and 
H-RASG12V (described in Barradas et al., 2009); pBOS-H2B-GFP (BD); and 
pPA-H2B-TagRFP (Evrogen). Retroviral-mediated gene transfer was performed 
using Phoenix packaging cells and polyethylenimine (PEI; Linear MW 
25,000; Polysciences, Inc.; Kennedy et al., 2011). Fibroblasts were drug 
selected with 1 µg/ml puromycin or 500 µg/ml neomycin and kept in drug for 
duration of experiments. For transient transfection of plasmids encoding 
GFP- or RFP-histone H2B, vectors were delivered by Amaxa nucleofection 
(solution R, X001 program). After 48 h, cells were seeded onto 3-cm glass-
bottom dishes (Iwaki America, Inc.) for subsequent time-lapse microscopy.
Melanocyte infection
Vesicular stomatitis virus G pseudotyped lentivectors encoding the oncogene 
BRAF600E under the transcriptional control of the cytomegalovirus initial 
early promoter and puromycin resistance from the simian virus 40 promoter 
were generated using standard methods (Kennedy et al., 2011). Melano-
cytes were infected overnight in normal culture medium supplemented with 
2 µg/ml polybrene (EMD Millipore) and thereafter cultured in the presence 
of 1 µg/ml puromycin for 13 d.
(O’Sullivan et al., 2010). Our results extend these observations 
to show that this phenomenon continues to occur after onset of 
senescence, as typically defined by molecular markers such as 
cell cycle exit, expression of p16INK4a and SA -gal. Although 
cellular senescence is commonly viewed as a static endpoint, 
previous reports have suggested that this may not be the case. 
These reports have characterized “early” senescence and “late” 
or “deep” senescence, based on analyses of DNA damage signal-
ing and expression of repetitive elements (Chen and Ozanne, 
2006; Passos et al., 2010; De Cecco et al., 2013). Proteolytic pro-
cessing of histones in senescent cells in vitro is linked to lyso-
somal activity, based on its association with activated cathepsin L 
(a lysosomal protease) and accumulation of H3.cs1, a cathepsin L 
cleavage product of full-length histone H3 (Duncan et al., 2008; 
Adams-Cioaba et al., 2011). Accumulation of H3.cs1 and deple-
tion of histones was suppressed by lysosomal vacuolar-type 
ATPase inhibitors, showing their dependence on lysosomal 
activity. Interestingly, because H3.cs1 is broadly associated with 
gene activation (Santos-Rosa et al., 2009), it is tempting to specu-
late that H3cs.1 might also have a role in changing the gene ex-
pression program in senescence.
Depletion of histones from senescent cells was not accom-
panied by a corresponding decrease in DNA content. So, even 
though histones appeared concentrated in CCFs (see Fig. 1 A), 
it seems likely that depletion of histones also occurs via CCF- 
independent mechanisms. Depletion of histones relative to DNA 
is expected to have profound consequences for the cell. Recently, 
Sedivy and colleagues reported “opening” and decompaction of 
chromatin at intergenic regions and pericentromeric satellite 
sequences of senescent cells (De Cecco et al., 2013). Moreover, 
“late” senescent cells exhibit increased expression and transposi-
tion of LINE-1 retrotransposons (De Cecco et al., 2013). Expres-
sion of Alu retrotransposons is also increased in senescent cells 
(Wang et al., 2011). Opening of chromatin structure caused by 
depletion of histones in senescent cells might contribute to this 
apparent dysregulation of the epigenome. Loss of heterochroma-
tin and altered genome function has been previously proposed to 
be a cause of cellular senescence and, ultimately, tissue aging 
(Howard, 1996; Villeponteau, 1997; Imai and Kitano, 1998). Of 
course, the cell might also counter the effects of histone deple-
tion on chromatin structure through mechanisms that remain to 
be determined. Consistent with this idea, Sedivy and coworkers 
have also shown that nuclear protein content actually increases 
in senescent cells (De Cecco et al., 2011), and some heterochroma-
tin proteins accumulate in physiologically aged tissues (Kreiling 
et al., 2011). On balance, it appears that cellular senescence is 
associated with a tendency to opening of chromatin due to deple-
tion of histones, but this is offset by compensatory mechanisms 
likely designed to maintain control of the genome. As a specific 
example, histone H1 is depleted from senescent cells and appar-
ently replaced by HMGA proteins (Funayama et al., 2006; Narita 
et al., 2006). To the extent that senescence contributes to physio-
logical aging, histone depletion and chromatin opening might be 
considered “degenerative” and compensatory changes as “pro-
tective.” A wealth of evidence, including recent genetic studies 
in model organisms, shows that chromatin features are altered 
with age and exert an important influence on aging and longevity 
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Samples were then washed 3× for 5 min each in PBST and then secondary 
Alexa Fluor 488 or 594 antibodies (1:500) were applied for 30 min. After 
washing, samples were stained with 1 µg/ml DAPI and embedded in Vecta-
Mount mounting medium (Vector Laboratories). Antibodies used for this study 
are as follows: lamin B1 (ab16048, 1:1,000; Abcam), histone H3 (3680, 
1:500; Cell Signaling Technology), MelanA (M7196, 1:50; Dako), and 
S100 (X0311, 1:400; Dako).
Automated quantitative fluorescence microscopy
After staining slides for immunofluorescence as described previously, random 
microscopy fields were captured at 60× original magnification (Plan Apo 
60×/1.4 NA oil lens; Nikon) and with a fluorescence microscope (Eclipse 
80i; Nikon) equipped with an Orca-ER CCV digital camera (Hamamatsu 
Photonics). Average nuclear fluorescence was measured within the linear fluor-
escence range, using MetaMorph software and integrated morphometry 
analysis module. Identical preparation, acquisition, and analysis parameters 
were used for comparative microscopy. At least 300 cells from at least 25 
random fields were analyzed per sample.
Immunoblotting
Cells were lysed in 1× Laemmli sample buffer and 5–20 µg of protein was 
resolved by SDS-PAGE followed by transfer onto PVDF membrane and prob-
ing with antibodies. Antibodies used in this study are as follows: anti-histone 
H3 (39163; Active Motif); anti-histone H2B (ab1790; Abcam); anti-histone 
H2A (ab18255; Abcam); anti-histone H4 (39269; Active Motif); anti– 
histone H4 (2935; Cell Signaling Technology); anti–lamin B1 (ab16048; 
Abcam); anti–lamin A/C (ab13910; Abcam); anti–LC3-B (ab48394; 
Abcam); anti–cyclin A (SC-754; Santa Cruz Biotechnology, Inc.); anti-p16 
(clone G175-405, 51-1325GR; BD); anti–cathepsin L (ab6314; Abcam); anti-
p53 (Ab-6, Pantropic, OP43; EMD Millipore); anti-H3cs.1 (39573; Active 
Motif); anti–-tubulin (T5168; Sigma-Aldrich); anti–rabbit IgG, HRP linked 
(NA934; GE Healthcare); and anti–mouse IgG, HRP linked (P0447; Dako).
Quantitation of DNA
DNA concentration was measured in 1 µl of cellular lysate in 1× Laemmli 
buffer using a Qubit fluorometer and a broad range dsDNA quantita-
tion kit.
Statistical analysis
Results shown are means ± SD or means ± SEM as indicated. P-value was 
calculated by student’s type-2 two-tailed t test.
Online supplemental material
Fig. S1 supports Fig. 1 and shows the proportion of lamin A/C–negative 
CCFs in relation to other markers of cellular senescence (Fig. S1 A), and lamin 
A/C staining control for bona fide micronuclei induced by Eg5 inhibitor III 
(Fig. S1 B). It also provides fluorescence in situ cytometry data showing higher 
content of histone H3 and -H2AX in CCFs in comparison to the main nuclei 
(Fig. S1, C and E). Fig. S1 D is related to Fig. 1 E and is a specificity control 
for antibodies against H3K27Me3 and H3K9Ac. Fig. 1 F shows the presence 
of -H2AX–positive CCFs in other biological models in vitro and in vivo. 
Fig. S2 is related to Fig. 2 and provides additional information on the looping 
of chromatin from the nuclei of senescent cells as well as on the loss of lamin 
B1 during RS and OIS in vitro and in benign nevi in vivo. Fig. S3 is related to 
Fig. 4 and shows up-regulated lysosomal compartment in cells undergoing 
OIS (Fig. S3, A and B), close association of CCFs with the p62 bodies 
(Fig. S3, D and E), IgG control for FK2 antibody (Fig. S3 F), and activation of 
cathepsin L during OIS (Fig. S3 G). Fig. S4 is related to Fig. 5 and provides 
additional information on the loss of histones in cells undergoing RS (Fig. S4 
A) and OIS (Fig. S4 B). Fig. S4, C–E are methodological and provide SA 
-Gal control for the onset of RS shown in Fig. 5 C and DNA measurements 
for subsequent normalization of loading by DNA content (Fig. S4 F). Fig. S5 is 
related to Fig. 5 and shows the loss of histones H3, H2A, and H2B in human 
nevi applying either DAB (Fig. S5, A and B) or fluorescence-related (Fig. S5 C) 
IHC methods. Fig. S5 A also shows MelanA, H&E, and IgG controls for 
Fig. S2 F. A common immunohistochemical p16 staining pattern in nevi is 
shown in Fig. S5 D. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201212110/DC1.
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Inhibition of V-ATPase
To inhibit V-ATPase activity, 50 nM bafilomycin A1 or 1 nM concanamycin 
A (both from Sigma-Aldrich) was added to cells for 24 h before harvesting.
Immunofluorescence
For immunofluorescence, cells growing on coverslips were fixed with metha-
nol at 20°C for 20 min and then rehydrated in TBS-HCl, pH 7.6. After two 
5-min washes in TBS/0.05% (vol/vol) Tween 20 (TBS-T), cells were blocked 
in TBS-T containing 2% (wt/vol) goat serum for 20 min. After that, cells were 
incubated in appropriately diluted (in TBS-T/2% [wt/vol] goat serum) pri-
mary antibodies for 1 h at room temperature. Primary antibodies used in this 
study were: histone H3 (39163, 1:1,000; Active Motif); -H2A.X (phosphor-
S139, ab11174, 1 µg/ml; Abcam), 53BP1 (4937, 1:500; Cell Signaling 
Technology), H3K27Me3 (39536, 1:5,000; Active Motif); H3K9Ac (39585, 
1:1,000; Active Motif); lamin A/C (ab13910, 1 µg/ml; Abcam); lamin B1 
(ab16048, 1 µg/ml; Abcam); p62SQSTM (SC-25575, 1 µg/ml; Santa Cruz 
Biotechnology, Inc.); and anti-ubiquitinated proteins, clone FK2 (04–263, 
1 µg/ml; EMD Millipore). As negative controls, the following IgG-matched 
antibodies were used: anti-HA tag (mouse IgG1, 2367; Cell Signaling Tech-
nology); anti–rabbit IgG (M7023; Sigma-Aldrich); and normal rabbit serum 
(S-5000; Vector Laboratories). After subsequent TBS-T washes, cells were in-
cubated with Alexa 488– or Alexa 594–conjugated secondary antibodies 
(Molecular Probes). Nuclei were counterstained with DAPI at 1 µg/ml.
Confocal microscopy
Confocal images have been obtained using a confocal microscope (model 
A1R; Nikon) and 60×/1.4 NA Plan Apo VC objective lens (Nikon). Images 
were obtained and brightness and contrast were adjusted using NIS-Elements 
AR3 software (Nikon) in compliance with the journal image policy.
Confocal time-lapse microscopy
For live-cell imaging, H2B-RFP– or H2B-GFP–expressing IMR-90 cells were 
seeded onto 3-cm glass-bottom dishes (Iwaki America, Inc.) 24 h before 
time lapse. Live-cell imaging was then performed in a humidified chamber 
at 37°C in a CO2-enriched atmosphere using a confocal microscope 
(model A1R; Nikon) equipped with a PanFluor 40×/1.30 NA objective 
lens (Nikon). Images were acquired and processed using NIS-Elements 
AR3 software (Nikon).
Dextran nuclear permeability assay
After harvesting, 2.5 × 106 cells were washed with 10 ml of cold PBS and then 
resuspended in 5 ml of cold hypotonic lysis buffer (1 mM KCl, 1.5 mM MgCl2, 
1 mM DTT, and 10 mM Tris-Cl, pH 8), supplemented with protease and phos-
phatase inhibitors. After 15 min incubation on ice, 10–20 strokes with a 
Dounce homogenizer were made. Intact nuclei, as monitored by phase- 
contrast microscopy, were pelleted at 500 g for 5 min and then resuspended 
in sucrose buffer (10 mM Tris-Cl, 5 mM EGTA, 80 mM KCl, 20 mM NaCl, and 
250 mM sucrose, pH 7.6). Texas red–conjugated 70-kD (D1829; Molecular 
Probes) and FITC-conjugated 500-kD (D7136; Molecular Probes) dextrans 
were added at 1:500, nuclei were carefully pipetted and, after 15 min incuba-
tion, transferred into 3-cm glass bottom dishes (Iwaki America, Inc.). Images 
were captured using either a fluorescence (Eclipse 80i; Nikon) or confocal 
(model A1R; Nikon) microscope. For scoring, images of cells were obtained 
based on Hoechst staining and then all cells were scored as positive or nega-
tive for dextran by visual assessment of images obtained in green (500-kD dex-
tran) or red (70-kD dextran) channels. At least 100 cells were scored in each 
of 4 replicates.
Immunohistochemistry
Immunohistochemistry was performed on paraffin-embedded human nevi 
obtained from the Fox Chase Cancer Center (Philadelphia, PA). Formalin-
fixed paraffin-embedded sections were deparaffinized and rehydrated by 
passage through xylene and a graded alcohol series. Endogenous peroxi-
dase activity was inactivated by treatment with 3% hydrogen peroxide, after 
which antigen retrieval was performed by incubation in boiling citrate buffer. 
Sections were blocked in 5% serum for 1 h, and then incubated with primary 
antibody for 1 h at room temperature or overnight at 4°C (for lamin B1). The 
following antibodies were used: anti-histone H3 (Clone 96C10, 3680; Cell 
Signaling Technology); anti-histone H2B (ab1790; Abcam); anti-histone 
H2A (ab18255; Abcam); anti-lamin B1 (ab16048; Abcam); and CINtec 
Histology kit for p16 (9511; MTM). Sections were then incubated in second-
ary antibody for 1 h (Envision+ kit [Dako] or Vectastain ABC system [Vector 
Laboratories]) and the staining was visualized with DAB.
Fluorescent-based immunohistochemistry
After dehydration, antigen retrieval, and protein blocking, tissue sections were 
incubated with primary antibodies, appropriately diluted with PBS-Tween 20. 
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